LOS ANGELES, Wednesday, July 6, 2016 – Last week, the Solve ME/CFS Initiative (SMCI) announced its creation of a new funding source for researchers, The Ramsay Award Program, offering competitive annual grants to scientists and researchers at any career stage who are interested in studying myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS). ME/CFS, also known as chronic fatigue and immune dysfunction syndrome (CFIDS), is a complex and debilitating disease affecting approximately 2.5 million Americans, one-quarter of which will end up either house- or bedbound within their lifetime.[i]

A Request for Applications launched this week, and applications will be accepted until 5:00 p.m. PST on Friday, July 29, 2016. The Ramsay Award Program is named after ME pioneer Dr. A. Melvin Ramsay, the recognized authority in ME from 1955 until his death in 1990, whose sound descriptions of the disease have stood the test of time.

“The Ramsay Award Program is part of our organization’s overall research strategy to encourage participatory investigations, accelerate new discoveries, and reduce barriers for entry into the challenging yet rewarding field of ME/CFS,” said Dr. Zaher Nahle, SMCI’s vice president for research and scientific programs.

Individual awards are expected to range between $35,000 and $55,000 for a one-year period, with the possibility of renewal for projects yielding promising results. Submitted proposals will be subject to a rigorous peer review process in order to ensure that only applications of the highest merit are selected.

About the Solve ME/CFS Initiative (SMCI)

The Solve ME/CFS Initiative (SMCI) was founded in 1987 and has established itself as the leading non-profit organization dedicated to ME/CFS. The organization’s mission is to make ME/CFS widely understood, diagnosable, and treatable by stimulating and conducting research aimed at the early detection, objective diagnosis, and effective treatment of ME/CFS. SMCI is the first and only ME/CFS organization to earn the highest possible distinction (a 4-star rating) from Charity Navigator, America’s largest independent charity evaluator.

[i] IOM (Institute of Medicine). 2015. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: Redefining an illness. Washington, DC: The National Academies Press.